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Background - One third of severe, symptomatic aortic stenosis (AS) patients are denied surgery due to advanced age and co-morbidities. The 
importance of risk stratification of unoperated AS is relevant as percutaneous aortic valve replacement is evolving as a treatment option for severe 
AS patients. We evaluated the impact of multiple clinical and echo-Doppler parameters on the prognosis on patients with unoperated severe AS.
Methods - We retrospectively identified 125 patients with unoperated severe AS. The primary endpoint was one year mortality. Clinical and echo-
Doppler parameters were compared between survivors and non-survivors. Tissue doppler parameters specifically evaluating diastolic dysfunction 
were obtained. Mortality data were obtained by Social Security Death Index.
Results - Overall one year survival was 62.4%. In univariate analysis survivors, compared to non-survivors, were younger (80.0±10.9 vs. 84.9±11.1, 
p=0.02), had higher Left Ventricular ejection fraction (LVEF) (55±15 vs. 50±16, p=0.042), higher LV stroke volume (63±19ml vs. 56±13, p = 0.015), 
lower E/E’ ratio (12.19±5.7 vs. 16.87±7.43, p < 0.001), and lower prevalence of E/E’>15 (20% vs. 55%, p < 0.001). There was no significant 
difference between symptom status (71% vs. 63%, p=0.379) or aortic valve area (0.7±0.2 vs 0.8±0.2, p=0.126). In multivariate analysis the only 
significant predictor of mortality was E/E’>15. This benefit was seen irrespective of LVEF. The adjusted mortality risk of E/E’>15 was 2.9 (95% 
confidence interval 1.1- 5.0, p=0.038).
Conclusion - The prognosis of unoperated severe AS is very poor. In patients with unoperated severe AS, E/E’>15 has independent prognostic 
significance and additive value to age and LVEF in identifying patients with a very high risk of dying within 1 year.
